Advertisement

Topics

#news #biotech Gemphire stock sinks as ex-Pfizer LDL drug data disappoint

09:26 EDT 7 Aug 2017 | Biotech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Gemphire stock sinks as ex-Pfizer LDL drug data disappoint .Gemphire Therapeutics has posted data on its oral inhibitor of cholesterol production. The phase 2b met its primary endpoint … Continue reading

Cet article #news #biotech Gemphire stock sinks as ex-Pfizer LDL drug data disappoint est apparu en premier sur Biotech 365.

Original Article: #news #biotech Gemphire stock sinks as ex-Pfizer LDL drug data disappoint

NEXT ARTICLE

More From BioPortfolio on "#news #biotech Gemphire stock sinks as ex-Pfizer LDL drug data disappoint"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Pfizer
Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...